Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women
- 1 April 1999
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (4) , 596-600
- https://doi.org/10.1016/s0959-8049(98)00428-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Insulin-like growth factor-I decreases serum lipoprotein(a) during long-term treatment of patients with Laron syndromeMetabolism, 1996
- Testosterone decreases lipoprotein(a) in menThe American Journal of Cardiology, 1996
- Hormonal Regulation of Serum Lipoprotein(a) LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women After 5 Years of TreatmentJNCI Journal of the National Cancer Institute, 1994
- A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.Circulation, 1994
- Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- The Relationship Between Serum Lipoprotein(a) and Insulinemia in Healthy Nondiabetic Adult MenDiabetes Care, 1994